Puma Biotechnology (PBYI) SEC Filings: History & Chart

Puma Biotechnology, Inc.(PBYI)

Biotechnology · Los Angeles, CA

$9.50-0.17 (-1.76%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.

Los Angeles, CA

179 employees

www.pumabiotechnology.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alan H. Auerbach

View full financials

Form	Filing Date	Accepted	Document
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Sep 16, 2026	Sep 16, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jul 8, 2026	Jul 8, 2026	View filing
4	Jul 8, 2026	Jul 8, 2026	View filing
4	Jul 8, 2026	Jul 8, 2026	View filing
8-K	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
10-Q	May 7, 2026	May 7, 2026	View filing
8-K	May 7, 2026	May 7, 2026	View filing
DEFA14A	Apr 28, 2026	Apr 28, 2026	View filing
ARS	Apr 28, 2026	Apr 28, 2026	View filing
DEF 14A	Apr 28, 2026	Apr 28, 2026	View filing
PRE 14A	Apr 7, 2026	Apr 7, 2026	View filing
SC 13G/A	Mar 27, 2026	Mar 27, 2026	View filing
10-K	Feb 26, 2026	Feb 26, 2026	View filing
8-K	Feb 26, 2026	Feb 26, 2026	View filing
4	Feb 20, 2026	Feb 20, 2026	View filing
4	Feb 20, 2026	Feb 20, 2026	View filing
4	Feb 20, 2026	Feb 20, 2026	View filing
4	Jan 8, 2026	Jan 8, 2026	View filing
4	Jan 8, 2026	Jan 8, 2026	View filing
4	Jan 8, 2026	Jan 8, 2026	View filing

SEC Filings

Recent Filings